Sumitomo Dainippon Pharma Co ( (JP:4506)) just unveiled an announcement. Sumitomo Pharma has received conditional and time-limited approval in Japan to manufacture and market AMCHEPRY, an allogeneic ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results